BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• 

  FDA

  FDA Approves Esperion’s Nexlizet for Lowering LDL-Cholesterol

  Nexlizet is expected to be on the market in the U.S. in July 2020.

  February 27, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Gilead Launches Two Phase III Trials of Remdesivir for COVID-19

  The randomized, open-label, multicenter studies will enroll about 1,000 patients mostly in Asia, as well as in countries that have had high numbers of diagnosed cases. The trials are planned to start in March.

  February 27, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  FDA

  FDA Approves Acacia Pharma’s Barhemsys for PONV

  The green light from the U.S. Food and Drug Administration marks the first approval for U.K.-based Acacia.

  February 27, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Arrowhead Pharmaceuticals: Pushing the Boundaries of Gene Silencing

  Christopher Anzalone, Arrowhead’s chief executive officer, took time to speak with BioSpace about the company’s large pipeline and why they’re so excited about 2020.

  February 27, 2020

   · 

  6 min read

   · 

  Mark Terry
• 

  Business

  Sponsored | How a Neurobiologist and a Biotech Manager Turned Their Passion for Science into Teaching

  A look at how two biotech professionals made the transition from research to inspiring students as biotech teachers with the help of EnCorps STEM Teachers Program.

  February 27, 2020

   · 

  4 min read

   · 

  EnCorps STEM Teachers Program
• Biotech Bay

  Augmented and Virtual Reality in Healthcare Market Future Scope Analysis to 2025

  Technological progress over the years have brought about a sea-change in the way in which patients are diagnosed and treated.

  February 27, 2020

   · 

  3 min read
• Pharm Country

  Surface Plasmon Resonance Market: Relevance of Studying Molecular Interactions in Clinical Research to Aid Growth

  Advancements in pharmaceutical manufacturing have created fresh opportunities for growth within the global surface plasmon market.

  February 27, 2020

   · 

  4 min read
• Pharm Country

  Development of Pneumatic Powered Wheelchairs Enhanced Growth in Wheelchair Market

  The use of wheelchairs has increased substantially mainly due to the rise in aged population.

  February 27, 2020

   · 

  5 min read
• 

  Policy

  Eli Lilly’s Cyramza Passes FDA Advisory Hurdle for NSCLC

  Eli Lilly’s Cyramza appears to be on its way to picking up its sixth approval from the U.S. Food and Drug Administration as a treatment for some lung cancer patients following narrow support from an advisory committee.

  February 27, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Eloxx Pharma Replaces CEO, Shifts Board to Refocus on Cystic Fibrosis Program

  The changes are designed to extend the company’s cash runway to the end of 2021.

  February 27, 2020

   · 

  2 min read

   · 

  Mark Terry